{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:03:41Z","timestamp":1794013421484,"version":"4.8.0"},"reference-count":208,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":497,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1038\/s41379-021-00820-y","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T23:46:51Z","timestamp":1621554411000},"page":"1634-1650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5054","authenticated-orcid":false,"given":"Sylvia L.","family":"Asa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0469-2801","authenticated-orcid":false,"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Cusimano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian E.","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8300-7261","authenticated-orcid":false,"given":"Arie","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Casar-Borota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"International Pituitary Pathology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Asioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcheyla Uyar","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil","family":"Comunoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Earls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuperi","family":"Gazioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilija","family":"Manojlovic-Gacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Messerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buge","family":"\u00d6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pakbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Roncaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Saeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Turchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sema","family":"Yarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-021-00820-y_bib1","unstructured":"Asa SL, Perry A. Tumors of the pituitary gland. AFIP Atlas of tumor and nontumor pathology, Series 5. Fascicle 1. Arlington VA: ARP Press; 2020."},{"key":"10.1038\/s41379-021-00820-y_bib2","unstructured":"Lloyd RV, Osamura RY, Kloppel G, Rosai J. WHO classification of tumours of endocrine organs, 4th ed. Lyon: IARC; 2017."},{"key":"10.1038\/s41379-021-00820-y_bib3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1159\/000507084","article-title":"Histopathology of parasellar neoplasms","volume":"110","author":"Manojlovic-Gacic","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1038\/s41379-021-00820-y_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00820-y_bib5","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1038\/s41379-021-00820-y_bib6","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pathol.2017.09.003","article-title":"Endocrine pathology: past, present and future","volume":"50","author":"Asa","year":"2018","journal-title":"Pathology"},{"key":"10.1038\/s41379-021-00820-y_bib8","first-page":"27","article-title":"The APUD cell concept and its implications in pathology","volume":"9","author":"Pearse","year":"1974","journal-title":"Pathol Annu"},{"key":"10.1038\/s41379-021-00820-y_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/jcm7090280","article-title":"The diagnosis and clinical significance of paragangliomas in unusual locations","volume":"7","author":"Asa","year":"2018","journal-title":"J Clin Med"},{"key":"10.1038\/s41379-021-00820-y_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPGZWXXBSNL4VD","article-title":"INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/jnen\/nly014","article-title":"INSM1 expression is frequent in primary central nervous system neoplasms but not in the adult brain parenchyma","volume":"77","author":"Ames","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/s41379-021-00820-y_bib12","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1126\/science.1062736","article-title":"Pituitary development: regulatory codes in mammalian organogenesis","volume":"295","author":"Scully","year":"2002","journal-title":"Science"},{"key":"10.1038\/s41379-021-00820-y_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","article-title":"The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas","volume":"26","author":"Nishioka","year":"2015","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00430697","article-title":"Null cell adenoma of the human pituitary","volume":"387","author":"Kovacs","year":"1980","journal-title":"Virchows Arch [Pathol Anat]"},{"key":"10.1038\/s41379-021-00820-y_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/nan.12568","article-title":"Invited review: pathology of pituitary neuroendocrine tumours: present status, modern diagnostic approach, controversies and future perspectives from a neuropathological and clinical standpoint","volume":"46","author":"Manojlovic-Gacic","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1038\/s41379-021-00820-y_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12022-018-9545-4","article-title":"Synchronous multiple pituitary neuroendocrine tumors of different cell lineages","volume":"29","author":"Mete","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12022-018-9562-3","article-title":"Plurihormonal pituitary tumor of Pit-1 and SF-1 lineages, with synchronous collision corticotroph tumor: a possible stem cell phenomenon","volume":"30","author":"Tordjman","year":"2019","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1038\/s41379-021-00820-y_bib19","unstructured":"DeLellis RA, Lloyd RV, Heitz PU, Eng C. Pathology and genetics of tumours of endocrine organs. 3rd ed. Lyon: IARC; 2004."},{"key":"10.1038\/s41379-021-00820-y_bib20","unstructured":"Kl\u00f6ppel G, In't Veld PA, Komminoth P, Heitz PhU. The endocrine pancreas. In: Kovacs K, Asa SL, editors. Functional endocrine pathology. Boston: Blackwell Science; 1998. p. 415\u201387."},{"key":"10.1038\/s41379-021-00820-y_bib21","first-page":"425","article-title":"Karzinoide tumoren des D\u00fcnndarms","volume":"1","author":"Oberndorfer","year":"1907","journal-title":"Frankf Z f\u00fcr Pathologie"},{"key":"10.1038\/s41379-021-00820-y_bib22","unstructured":"Travis WD, Burke AP, Marx A, Nicholson AG. WHO classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon: IARC; 2015."},{"key":"10.1038\/s41379-021-00820-y_bib23","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib24","unstructured":"Lyssikatos C, Fauez FR, Stratakis CA. Familial endocrine tumor syndromes. In: Mete O, Asa SL, editors. Endocrine pathology. Cambridge: Cambridge University Press; 2016. p. 56\u201370."},{"key":"10.1038\/s41379-021-00820-y_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"10.1038\/s41379-021-00820-y_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/his.13402","article-title":"Pathology and genetics of phaeochromocytoma and paraganglioma","volume":"72","author":"Turchini","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00820-y_bib27","doi-asserted-by":"crossref","unstructured":"Seabrook AJ, Harris JE, Velosa SB, Kim E, McInerney-Leo AM, Dwight T, et al. Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5? J Clin Endocrinol Metab. 2020;106:1163\u201382.","DOI":"10.1210\/clinem\/dgaa957"},{"key":"10.1038\/s41379-021-00820-y_bib28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.humpath.2018.03.018","article-title":"Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3","volume":"77","author":"Konukiewitz","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib29","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/modpathol.2016.220","article-title":"Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas","volume":"30","author":"Jesinghaus","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11276-9","article-title":"Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids","volume":"10","author":"Alcala","year":"2019","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-021-00820-y_bib31","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-021-00820-y_bib32","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/ERC-16-0496","article-title":"Pituitary acromegaly: not one disease","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-021-00820-y_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.2015.151","article-title":"Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas","volume":"29","author":"Mete","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12022-015-9395-2","article-title":"Monomorphous plurihormonal pituitary adenoma of Pit-1 lineage in a giant adolescent with central hyperthyroidism","volume":"27","author":"Pereira","year":"2016","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib35","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-021-00820-y_bib36","first-page":"205","article-title":"Subclinical adenoma of the pituitary gland","volume":"12","author":"Costello","year":"1936","journal-title":"Am J Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib37","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM198101153040306","article-title":"Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series","volume":"304","author":"Burrow","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-021-00820-y_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1148\/radiology.187.1.8451394","article-title":"Modern imaging of the pituitary","volume":"187","author":"Elster","year":"1993","journal-title":"Radiology"},{"key":"10.1038\/s41379-021-00820-y_bib39","doi-asserted-by":"crossref","first-page":"bvaa021","DOI":"10.1210\/jendso\/bvaa021","article-title":"Presenting features in 269 patients with clinically nonfunctioning pituitary adenomas enrolled in a prospective study","volume":"4","author":"Freda","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1038\/s41379-021-00820-y_bib40","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/geronj\/35.1.16","article-title":"Pituitary adenomas in old age","volume":"35","author":"Kovacs","year":"1980","journal-title":"J Gerontol"},{"key":"10.1038\/s41379-021-00820-y_bib41","first-page":"488","article-title":"Subclinical adenomas of the human pituitary. New light on old problems","volume":"107","author":"McComb","year":"1983","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00820-y_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","article-title":"Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)","volume":"72","author":"Fernandez","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/EJE-15-0189","article-title":"The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study","volume":"173","author":"Agustsson","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib44","first-page":"2172","article-title":"Epidemiology of pituitary adenoma: results of the first Swiss study","volume":"5","author":"Fontana","year":"2009","journal-title":"Rev Med Suisse"},{"key":"10.1038\/s41379-021-00820-y_bib45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1530\/EJE-14-0144","article-title":"The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011","volume":"171","author":"Tjornstrand","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib46","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1038\/s41379-021-00820-y_bib47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11102-020-01084-6","article-title":"Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study","volume":"24","author":"Oh","year":"2021","journal-title":"Pituitary"},{"key":"10.1038\/s41379-021-00820-y_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","article-title":"The epidemiology of pituitary adenomas","volume":"49","author":"Daly","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1038\/s41379-021-00820-y_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3171\/jns.1978.48.1.0013","article-title":"Transsphenoidal microsurgical removal of 250 pituitary adenomas","volume":"48","author":"Wilson","year":"1978","journal-title":"J Neurosurg"},{"key":"10.1038\/s41379-021-00820-y_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF02738730","article-title":"Incidence, pathology, and recurrence of pituitary adenomas: Study of 647 unselected surgical cases","volume":"6","author":"Terada","year":"1995","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib51","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJM199103213241207","article-title":"Diagnosis and management of hormone-secreting pituitary adenomas","volume":"324","author":"Klibanski","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-021-00820-y_bib52","unstructured":"Kovacs K, Horvath E. Tumors of the pituitary gland. Atlas of tumor pathology, second series, Fascicle 21. Washington, D.C.: Armed Forces Institute of Pathology; 1986."},{"key":"10.1038\/s41379-021-00820-y_bib53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2265.1999.00748.x","article-title":"Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas\u2014results of a prospective study","volume":"51","author":"Feldkamp","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib54","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41379-018-0016-8","article-title":"Epidemiology and biomarker profile of pituitary adenohypophysial tumors","volume":"31","author":"Mete","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2265.1994.tb02557.x","article-title":"Age-related and gender-related occurrence of pituitary adenomas","volume":"41","author":"Mindermann","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib56","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fendo.2018.00706","article-title":"Sex-related differences in lactotroph tumor aggressiveness are associated with a specific gene-expression signature and genome instability","volume":"9","author":"Wierinckx","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib57","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ecl.2014.10.001","article-title":"A prognostic clinicopathologic classification of pituitary endocrine tumors","volume":"44","author":"Raverot","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1038\/s41379-021-00820-y_bib58","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.wneu.2016.09.051","article-title":"Surgical results of pure endoscopic endonasal transsphenoidal surgery for 331 pituitary adenomas: a 15-year experience from a single institution","volume":"96","author":"Jang","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1038\/s41379-021-00820-y_bib59","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1038\/s41379-021-00820-y_bib60","unstructured":"Hardy J. Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, editors. Diagnosis and treatment of pituitary tumors. International Congress Series No. 303. Amsterdam: Exerpta Medica; 1973. p. 179\u201398."},{"key":"10.1038\/s41379-021-00820-y_bib61","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2016-4061","article-title":"Outcome of nonfunctioning pituitary adenomas that regrow after primary treatment: a study from two large UK centers","volume":"102","author":"Tampourlou","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib62","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1530\/JME-12-0113","article-title":"Biomarkers of aggressive pituitary adenomas","volume":"49","author":"Mete","year":"2012","journal-title":"J Mol Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12022-018-9521-z","article-title":"Immunohistochemical biomarkers in pituitary pathology","volume":"29","author":"Asa","year":"2018","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib64","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.surneu.2007.05.057","article-title":"Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results","volume":"68","author":"Santoro","year":"2007","journal-title":"Surg Neurol"},{"key":"10.1038\/s41379-021-00820-y_bib65","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12020-017-1458-3","article-title":"Microsurgical therapy of pituitary adenomas","volume":"59","author":"Mortini","year":"2018","journal-title":"Endocrine"},{"key":"10.1038\/s41379-021-00820-y_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/EJE-18-0749","article-title":"Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre","volume":"180","author":"Asioli","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3171\/2014.3.JNS132214","article-title":"Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes","volume":"121","author":"Nishioka","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1038\/s41379-021-00820-y_bib68","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1210\/jc.2011-0554","article-title":"Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome","volume":"96","author":"Jane","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib69","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1210\/jc.2013-1036","article-title":"Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission","volume":"98","author":"Starke","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib70","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3171\/jns.1998.89.3.0353","article-title":"Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly","volume":"89","author":"Freda","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1038\/s41379-021-00820-y_bib71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/eje.1.01863","article-title":"The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical \u2018cure\u2018","volume":"152","author":"Nomikos","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib72","first-page":"3419","article-title":"Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly","volume":"83","author":"Swearingen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12020-018-1590-8","article-title":"Predictors of surgical outcome and early criteria of remission in acromegaly","volume":"60","author":"Antunes","year":"2018","journal-title":"Endocrine"},{"key":"10.1038\/s41379-021-00820-y_bib74","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10143-015-0613-7","article-title":"Endoscopic versus microscopic approach for surgical treatment of acromegaly","volume":"38","author":"Fathalla","year":"2015","journal-title":"Neurosurg Rev"},{"key":"10.1038\/s41379-021-00820-y_bib75","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00701-017-3318-6","article-title":"Microsurgical versus endoscopic transsphenoidal resection for acromegaly: a systematic review of outcomes and complications","volume":"159","author":"Chen","year":"2017","journal-title":"Acta Neurochir"},{"key":"10.1038\/s41379-021-00820-y_bib76","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib77","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/S031716710001427X","article-title":"Impact of technique on cushing disease outcome using strict remission criteria","volume":"40","author":"Alahmadi","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"10.1038\/s41379-021-00820-y_bib78","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1507\/endocrj.15-0463","article-title":"Therapeutic outcomes in patients undergoing surgery after diagnosis of Cushing's disease: a single-center study","volume":"62","author":"Yamada","year":"2015","journal-title":"Endocr J"},{"key":"10.1038\/s41379-021-00820-y_bib79","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.wneu.2018.07.055","article-title":"Outcome of transsphenoidal surgery for Cushing disease: a single-center experience over 20 years","volume":"119","author":"Brichard","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1038\/s41379-021-00820-y_bib80","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing's disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1038\/s41379-021-00820-y_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/neuros\/nyx378","article-title":"Cushing's disease: lessons learned from 1500 cases","volume":"64","author":"Oldfield","year":"2017","journal-title":"Neurosurgery"},{"key":"10.1038\/s41379-021-00820-y_bib82","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3171\/jns.2002.97.6.1343","article-title":"Basis of persistent and recurrent Cushing disease: an analysis of findings at repeated pituitary surgery","volume":"97","author":"Dickerman","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1038\/s41379-021-00820-y_bib83","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1210\/jc.2013-3054","article-title":"Growth patterns of pituitary adenomas and histopathological correlates","volume":"99","author":"Monsalves","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib84","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00701-019-03879-4","article-title":"Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas","volume":"161","author":"Grimm","year":"2019","journal-title":"Acta Neurochir"},{"key":"10.1038\/s41379-021-00820-y_bib85","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1227\/01.NEU.0000349930.66434.82","article-title":"Ki-67 in pituitary neoplasms: a review-part I","volume":"65","author":"Salehi","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1038\/s41379-021-00820-y_bib86","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1530\/eje.0.1330686","article-title":"In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide","volume":"133","author":"Ezzat","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib87","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1210\/jc.2005-0998","article-title":"The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly","volume":"90","author":"Bhayana","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04286.x","article-title":"Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly","volume":"77","author":"Heck","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib89","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2265.2011.04163.x","article-title":"Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly","volume":"76","author":"Fougner","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib90","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4158\/EP-2018-0500","article-title":"Predictive markers fo postsurgical medical management of acromegaly: a systematic review and consensus treatment guideline","volume":"25","author":"Ezzat","year":"2019","journal-title":"Endocr Pr"},{"key":"10.1038\/s41379-021-00820-y_bib91","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/EJE-15-0689","article-title":"The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease","volume":"174","author":"Hayashi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib92","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/cr.2015.20","article-title":"Recurrent gain-of-function USP8 mutations in Cushing's disease","volume":"25","author":"Ma","year":"2015","journal-title":"Cell Res"},{"key":"10.1038\/s41379-021-00820-y_bib93","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12022-014-9347-2","article-title":"Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics","volume":"26","author":"Balogun","year":"2015","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib94","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11102-019-00981-9","article-title":"Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers","volume":"22","author":"Almeida","year":"2019","journal-title":"Pituitary"},{"key":"10.1038\/s41379-021-00820-y_bib95","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2020.3.FOCUS20114","article-title":"Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution","volume":"48","author":"Haddad","year":"2020","journal-title":"Neurosurg Focus"},{"key":"10.1038\/s41379-021-00820-y_bib96","first-page":"1210","article-title":"Recurrence in silent corticotroph adenomas after primary treatment: a systematic review and meta-analysis","volume":"10","author":"Fountas","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib97","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.wneu.2018.08.043","article-title":"Nonfunctioning pituitary adenoma recurrence and its relationship with sex, size, and hormonal immunohistochemical profile","volume":"120","author":"Batista","year":"2018","journal-title":"World Neurosurg"},{"key":"10.1038\/s41379-021-00820-y_bib98","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jc.2008-0643","article-title":"Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib99","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000339823","article-title":"Natural history of postoperative nonfunctioning pituitary adenomas: a systematic review and meta-analysis","volume":"96","author":"Chen","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1038\/s41379-021-00820-y_bib100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12022-013-9270-y","article-title":"The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas","volume":"24","author":"Mete","year":"2013","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib101","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00701-012-1378-1","article-title":"Clinical features of silent corticotroph adenomas","volume":"154","author":"Alahmadi","year":"2012","journal-title":"Acta Neurochir"},{"key":"10.1038\/s41379-021-00820-y_bib102","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.humpath.2004.04.016","article-title":"Silent corticotroph adenomas: further clinical and pathological observations","volume":"35","author":"Lopez","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib103","first-page":"723","article-title":"Clinically silent corticotroph tumors of the pituitary gland","volume":"47","author":"Scheithauer","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1038\/s41379-021-00820-y_bib104","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1210\/jc.2018-00688","article-title":"Clinical and pathological aspects of silent pituitary adenomas","volume":"104","author":"Drummond","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib105","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/01913120500323514","article-title":"Silent adenoma subtype 3 of the pituitary-immunohistochemical and ultrastructural classification: a review of 29 cases","volume":"29","author":"Horvath","year":"2005","journal-title":"Ultrastruct Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib106","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2008.03514.x","article-title":"Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience","volume":"71","author":"Erickson","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib107","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/00000478-200310000-00005","article-title":"Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma","volume":"27","author":"George","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib108","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1227\/NEU.0000000000000657","article-title":"Crooke's cell tumors of the pituitary","volume":"76","author":"Di Ieva","year":"2015","journal-title":"Neurosurgery"},{"key":"10.1038\/s41379-021-00820-y_bib109","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.wneu.2020.02.137","article-title":"Aggressive pituitary tumor with Crooke's cells and invasion of the posterior fossa","volume":"138","author":"Cortez","year":"2020","journal-title":"World Neurosurg"},{"key":"10.1038\/s41379-021-00820-y_bib110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-10-0586","article-title":"Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae","volume":"163","author":"Bakhtiar","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib111","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-12-0864","article-title":"Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas","volume":"168","author":"Larkin","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib112","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12020-014-0383-y","article-title":"Growth hormone tumor histological subtypes predict response to surgical and medical therapy","volume":"49","author":"Kiseljak-Vassiliades","year":"2015","journal-title":"Endocrine"},{"key":"10.1038\/s41379-021-00820-y_bib113","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1097-0142(19810215)47:4<761::AID-CNCR2820470422>3.0.CO;2-L","article-title":"Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases","volume":"47","author":"Horvath","year":"1981","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00820-y_bib114","first-page":"594","article-title":"Acidophil stem cell adenoma of the human pituitary","volume":"101","author":"Horvath","year":"1977","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00820-y_bib115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1515\/JPEM.2006.19.7.951","article-title":"Dopaminergic resistant prolactinomas in the peripubertal population","volume":"19","author":"Huang","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib116","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jcem.84.2.5505","article-title":"Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health","volume":"84","author":"Brucker-Davis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib117","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","article-title":"A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up","volume":"126","author":"Trouillas","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1038\/s41379-021-00820-y_bib118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrendo.2014.64","article-title":"Aggressive pituitary adenomas-diagnosis and emerging treatments","volume":"10","author":"Di Ieva","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib119","doi-asserted-by":"crossref","first-page":"R331","DOI":"10.1530\/ERC-14-0188","article-title":"The PI3K\/AKT\/mTOR pathway in the pathophysiology and treatment of pituitary adenomas","volume":"21","author":"Monsalves","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-021-00820-y_bib120","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2217\/cns-2016-0011","article-title":"Widely metastatic atypical pituitary adenoma with mTOR pathway STK11(F298L) mutation treated with everolimus therapy","volume":"5","author":"Donovan","year":"2016","journal-title":"CNS Oncol"},{"key":"10.1038\/s41379-021-00820-y_bib121","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/cncr.25413","article-title":"Treatment of pituitary neoplasms with temozolomide: a review","volume":"117","author":"Syro","year":"2011","journal-title":"Cancer"},{"key":"10.1038\/s41379-021-00820-y_bib122","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/EJE-17-0933","article-title":"Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016","volume":"178","author":"McCormack","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib123","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib124","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11154-020-09551-y","article-title":"Temozolomide therapy for aggressive pituitary tumours - current understanding and future perspectives","volume":"21","author":"Burman","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1038\/s41379-021-00820-y_bib125","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1210\/jc.2014-4350","article-title":"Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide","volume":"100","author":"Bengtsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib126","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1210\/jc.2010-0441","article-title":"Temozolomide treatment for aggressive pituitary tumors: correlation of clinical outcome with O(6)-methylguanine methyltransferase (MGMT) promoter methylation and expression","volume":"95","author":"Bush","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib127","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s11102-009-0211-1","article-title":"Temozolomide (Temodar(R)) and capecitabine (Xeloda(R)) treatment of an aggressive corticotroph pituitary tumor","volume":"14","author":"Thearle","year":"2011","journal-title":"Pituitary"},{"key":"10.1038\/s41379-021-00820-y_bib128","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1227\/NEU.0000000000000251","article-title":"High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series","volume":"74","author":"Zacharia","year":"2014","journal-title":"Neurosurgery"},{"key":"10.1038\/s41379-021-00820-y_bib129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12022-019-9568-5","article-title":"An institutional experience of tumor progression to pituitary carcinoma in a 15-year cohort of 1055 consecutive pituitary neuroendocrine tumors","volume":"30","author":"Alshaikh","year":"2019","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-18-0795","article-title":"Treatment and long-term outcomes in pituitary carcinoma: a cohort study","volume":"181","author":"Santos-Pinheiro","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib131","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1007\/s11102-011-0373-5","article-title":"First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment","volume":"15","author":"Baldari","year":"2012","journal-title":"Pituitary"},{"key":"10.1038\/s41379-021-00820-y_bib132","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9343(54)90353-8","article-title":"Genetic aspects of adenomatosis of endocrine glands","volume":"16","author":"Wermer","year":"1954","journal-title":"Am J Med"},{"key":"10.1038\/s41379-021-00820-y_bib133","first-page":"494","article-title":"Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic and molecular features","volume":"72","author":"DeLellis","year":"1995","journal-title":"Lab Invest"},{"key":"10.1038\/s41379-021-00820-y_bib134","first-page":"205","article-title":"Pituitary adenomas of the multiple endocrine neoplasia type I syndrome","volume":"4","author":"Scheithauer","year":"1987","journal-title":"Semin Diagn Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib135","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib136","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1507\/endocrj.42.331","article-title":"Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features","volume":"42","author":"Shintani","year":"1995","journal-title":"Endocr J"},{"key":"10.1038\/s41379-021-00820-y_bib137","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2013.08.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)","volume":"386","author":"Thakker","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib138","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/cen.12614","article-title":"Breast cancer risk in MEN1\u2014a cancer genetics perspective","volume":"82","author":"Brennan","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib139","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1038\/s41379-021-00820-y_bib140","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1210\/jc.2006-2843","article-title":"Germline CDKN1B\/p27Kip1 mutation in multiple endocrine neoplasia","volume":"92","author":"Georgitsi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib141","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neop(2009)lasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib142","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.beem.2010.01.001","article-title":"MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations","volume":"24","author":"Georgitsi","year":"2010","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib143","doi-asserted-by":"crossref","first-page":"T195","DOI":"10.1530\/ERC-17-0243","article-title":"MEN4 and CDKN1B mutations: the latest of the MEN syndromes","volume":"24","author":"Alrezk","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-021-00820-y_bib144","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1210\/clinem\/dgaa142","article-title":"Clinical MEN-1 among a large cohort of patients with acromegaly","volume":"105","author":"Nachtigall","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib145","doi-asserted-by":"crossref","first-page":"bvaa142","DOI":"10.1210\/jendso\/bvaa142","article-title":"Multiple endocrine neoplasia type 1 (MEN1) phenocopy due to a cell cycle division 73 (CDC73) variant","volume":"4","author":"Lines","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1038\/s41379-021-00820-y_bib146","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine"},{"key":"10.1038\/s41379-021-00820-y_bib147","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-021-00820-y_bib148","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1210\/me.2006-0428","article-title":"Pituitary-specific knockout of the Carney complex gene prkar1a leads to pituitary tumorigenesis","volume":"22","author":"Yin","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib149","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/his.13277","article-title":"Succinate dehydrogenase (SDH)-deficient neoplasia","volume":"72","author":"Gill","year":"2018","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00820-y_bib150","doi-asserted-by":"crossref","first-page":"C33","DOI":"10.1530\/ERC-12-0118","article-title":"Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and\/or Krebs cycle defects?","volume":"19","author":"Xekouki","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1038\/s41379-021-00820-y_bib151","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.humpath.2011.12.012","article-title":"Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature","volume":"43","author":"Karamurzin","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib152","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1210\/jc.2017-01401","article-title":"Corticotroph pituitary carcinoma in a patient with lynch syndrome (LS) and pituitary tumors in a nationwide LS cohort","volume":"102","author":"Bengtsson","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib153","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11102-005-0-04-0","article-title":"Isolated familial somatotropinoma","volume":"7","author":"Soares","year":"2004","journal-title":"Pituitary"},{"key":"10.1038\/s41379-021-00820-y_bib154","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/EJE-07-0348","article-title":"The clinical, pathological, and genetic features of familial isolated pituitary adenomas","volume":"157","author":"Beckers","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"key":"10.1038\/s41379-021-00820-y_bib156","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2265.2008.03266.x","article-title":"Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas","volume":"69","author":"Georgitsi","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib157","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-08-0593","article-title":"Aryl hydrocarbon receptor-interacting protein and pituitary adenomas: a population-based study on subjects exposed to dioxin after the Seveso, Italy, accident","volume":"159","author":"Pesatori","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib158","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers","volume":"100","author":"Hernandez-Ramirez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib159","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-021-00820-y_bib160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM199008023230507","article-title":"Gigantism due to pituitary mammosomatotroph hyperplasia","volume":"323","author":"Moran","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1038\/s41379-021-00820-y_bib161","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12022-021-09663-4","article-title":"Genomics and epigenomics of pituitary tumors: what do pathologists need to know?","volume":"32","author":"Asa","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib162","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/jcem-71-6-1421","article-title":"Clinical, biochemical and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase","volume":"71","author":"Spada","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib163","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/js.2017-00364","article-title":"USP8 mutations in pituitary Cushing adenomas-targeted analysis by next-generation sequencing","volume":"2","author":"Ballmann","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1038\/s41379-021-00820-y_bib164","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"key":"10.1038\/s41379-021-00820-y_bib165","unstructured":"Casar-Borota O, Boldt HB, Engstrom BE, Andersen MS, Baussart B, Bengtsson D, et al. Corticotroph aggressive pituitary tumours and carcinomas frequently harbour ATRX mutations. J Clin Endocrinol Metab. in press. 2021."},{"key":"10.1038\/s41379-021-00820-y_bib166","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"10.1038\/s41379-021-00820-y_bib167","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","author":"Fishbein","year":"2015","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-021-00820-y_bib168","doi-asserted-by":"crossref","first-page":"E796","DOI":"10.1210\/jc.2012-4028","article-title":"Whole-exome sequencing studies of nonfunctioning pituitary adenomas","volume":"98","author":"Newey","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib169","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1158\/1078-0432.CCR-16-0790","article-title":"Landscape of genomic alterations in pituitary adenomas","volume":"23","author":"Bi","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-021-00820-y_bib170","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2017-02287","article-title":"Genomic alterations and complex subclonal architecture in sporadic GH-secreting pituitary adenomas","volume":"103","author":"Hage","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib171","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12022-019-09587-0","article-title":"The genomic landscape of sporadic prolactinomas","volume":"30","author":"De Sousa","year":"2019","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib172","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1172\/JCI138540","article-title":"DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas","volume":"130","author":"Ben-Shlomo","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1038\/s41379-021-00820-y_bib173","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-15-0373","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-021-00820-y_bib174","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mce.2017.07.011","article-title":"Epigenetics of pituitary tumors: pathogenetic and therapeutic implications","volume":"469","author":"Ezzat","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib175","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1210\/jc.2009-2032","article-title":"Subtle cognitive impairments in patients with long-term cure of Cushing's disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib176","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1210\/jc.2010-1253","article-title":"Increased psychopathology and maladaptive personality traits, but normal cognitive functioning, in patients after long-term cure of acromegaly","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/s41379-021-00820-y_bib177","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/EJE-08-0896","article-title":"Personality in patients with pituitary adenomas is characterized by increased anxiety-related traits: comparison of 70 acromegalic patients with patients with non-functioning pituitary adenomas and age- and gender-matched controls","volume":"160","author":"Sievers","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/s41379-021-00820-y_bib178","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.urolonc.2009.03.001","article-title":"Impact of surgeon and hospital volume on outcomes of radical prostatectomy","volume":"28","author":"Barocas","year":"2010","journal-title":"Urol Oncol"},{"key":"10.1038\/s41379-021-00820-y_bib179","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jpedsurg.2011.12.003","article-title":"Subspecialization may improve an esophageal atresia service but has not addressed declining trainee experience","volume":"47","author":"Jawaid","year":"2012","journal-title":"J Pediatr Surg"},{"key":"10.1038\/s41379-021-00820-y_bib180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4103\/2152-7806.105102","article-title":"Endocrine surgery as a model for value-based health care delivery","volume":"3","author":"Abdulla","year":"2012","journal-title":"Surg Neurol Int"},{"key":"10.1038\/s41379-021-00820-y_bib181","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/ajmg.a.35795","article-title":"Contributions of a specialty clinic for children and adolescents with Down syndrome","volume":"161A","author":"Skotko","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1038\/s41379-021-00820-y_bib182","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1097\/ACM.0000000000000000","article-title":"Specializing in accountability: strategies to prepare a subspecialty workforce for care delivery redesign","volume":"88","author":"Nambudiri","year":"2013","journal-title":"Acad Med"},{"key":"10.1038\/s41379-021-00820-y_bib183","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1200\/JOP.2013.001204","article-title":"Second-opinion pathologic review is a patient safety mechanism that helps reduce error and decrease waste","volume":"10","author":"Middleton","year":"2014","journal-title":"J Oncol Pr"},{"key":"10.1038\/s41379-021-00820-y_bib184","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/2153-3539.139714","article-title":"Can digital pathology result in cost savings? A financial projection for digital pathology implementation at a large integrated health care organization","volume":"5","author":"Ho","year":"2014","journal-title":"J Pathol Inf"},{"key":"10.1038\/s41379-021-00820-y_bib185","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3174\/ajnr.A4089","article-title":"Radiology reports for incidental thyroid nodules on CT and MRI: high variability across subspecialties","volume":"36","author":"Grady","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1038\/s41379-021-00820-y_bib186","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejogrb.2014.11.015","article-title":"The impact of gynecologic oncology training in the management of cancer patients: is it really necessary? A prospective cohort study","volume":"184","author":"Plotti","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1038\/s41379-021-00820-y_bib187","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/imj.12909","article-title":"Subspecialisation in cardiology care and outcome: should clinical services be redesigned, again?","volume":"46","author":"Pathik","year":"2016","journal-title":"Intern Med J"},{"key":"10.1038\/s41379-021-00820-y_bib188","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00586-016-4545-x","article-title":"The role of specialist units to provide focused care and complication avoidance following traumatic spinal cord injury: a systematic review","volume":"25","author":"Maharaj","year":"2016","journal-title":"Eur Spine J"},{"key":"10.1038\/s41379-021-00820-y_bib189","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.acap.2016.05.147","article-title":"Family perspectives on high-quality pediatric subspecialty referrals","volume":"16","author":"Ray","year":"2016","journal-title":"Acad Pediatr"},{"key":"10.1038\/s41379-021-00820-y_bib190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5858\/arpa.2017-0139-OA","article-title":"Integrated pathology informatics enables high-quality personalized and precision medicine: digital pathology and beyond","volume":"142","author":"Volynskaya","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00820-y_bib191","doi-asserted-by":"crossref","first-page":"640","DOI":"10.5858\/2010-0470-SAR1.1","article-title":"Protocol for the examination of specimens from patients with primary pituitary tumors","volume":"135","author":"Nose","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/s41379-021-00820-y_bib192","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ecl.2020.05.010","article-title":"Pituitary tumors centers of excellence","volume":"49","author":"Frara","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1038\/s41379-021-00820-y_bib193","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1007\/s00428-007-0461-0","article-title":"Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors","volume":"451","author":"Kloppel","year":"2007","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-021-00820-y_bib194","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1038\/s41379-021-00820-y_bib195","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/annonc\/12.suppl_2.S63","article-title":"The gut as the largest endocrine organ in the body","volume":"12","author":"Nilsson","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-021-00820-y_bib196","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/jcp.37.8.931","article-title":"Amine and peptide hormone production by lung carcinoid: a clinicopathological and immunocytochemical study","volume":"37","author":"Bosman","year":"1984","journal-title":"J Clin Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib197","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000444803","article-title":"Four neuroendocrine tumor types and neuroendocrine carcinoma of the duodenum: analysis of 203 cases","volume":"104","author":"Vanoli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1038\/s41379-021-00820-y_bib198","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4143\/crt.2014.238","article-title":"Prognostic significance of defining L-cell type on the biologic behavior of rectal neuroendocrine tumors in relation with pathological parameters","volume":"47","author":"Sohn","year":"2015","journal-title":"Cancer Res Treat"},{"key":"10.1038\/s41379-021-00820-y_bib199","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/PAS.0000000000000400","article-title":"Non-L-cell immunophenotype and large tumor size in rectal neuroendocrine tumors are associated with aggressive clinical behavior and worse prognosis","volume":"39","author":"Kim","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib200","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/PAS.0b013e3182819f0f","article-title":"Rectal neuroendocrine and L-cell tumors: diagnostic dilemma and therapeutic strategy","volume":"37","author":"Lee","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib201","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/edrv-9-3-357","article-title":"Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations","volume":"9","author":"Sano","year":"1988","journal-title":"Endocr Rev"},{"key":"10.1038\/s41379-021-00820-y_bib202","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00428-019-02612-x","article-title":"ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature","volume":"475","author":"La Rosa","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1038\/s41379-021-00820-y_bib203","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/ajcp\/87.3.327","article-title":"Immunohistologic localization of corticotrophin-releasing hormone in human tumors","volume":"87","author":"Asa","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib204","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12022-017-9505-4","article-title":"Calcitonin-producing neuroendocrine neoplasms of the pancreas: clinicopathological study of 25 cases and review of the literature","volume":"28","author":"Uccella","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib205","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PAS.0000000000000340","article-title":"ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature","volume":"39","author":"Maragliano","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/s41379-021-00820-y_bib206","doi-asserted-by":"crossref","unstructured":"Uccella S, Asa SL, Mete O. Neuroendocrine neoplasms of unknown primary site. In: Asa SL, La Rosa S, Mete O, editors. The spectrum of neuroendocrine neoplasia. Cham, Switzerland: Springer; Chapter 16, 2020;357\u201388.","DOI":"10.1007\/978-3-030-54391-4_16"},{"key":"10.1038\/s41379-021-00820-y_bib207","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3390\/cancers11060828","article-title":"Treatment options for pancreatic neuroendocrine tumors","volume":"11","author":"Akirov","year":"2019","journal-title":"Cancers"},{"key":"10.1038\/s41379-021-00820-y_bib208","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1530\/ERC-16-0538","article-title":"Effect of hormone secretory syndromes on neuroendocrine tumor prognosis","volume":"24","author":"Zandee","year":"2017","journal-title":"Endocr Relat Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00820-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00820-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222005439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-021-00820-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:36:33Z","timestamp":1760229393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222005439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":208,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0893395222005439"],"URL":"https:\/\/doi.org\/10.1038\/s41379-021-00820-y","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-021-00820-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}